Tacrolimus Generics - Manufacturers & Suppliers
US: Prograf IR, Astagraf XL; EU: Prograf,Advagraf(PR)
| Product/Composition:- | Tacrolimus |
|---|---|
| Strength:- | IR:0.5 mg, 1 mg , 5 mg; ER: 0.5 mg, 1 mg, 3 mg, 5 mg |
| Form:- | Capsule |
| Reference Brands:- | US: Prograf IR, Astagraf XL; EU: Prograf,Advagraf(PR) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Tacrolimus Capsules are immunosuppressive agents used to prevent organ transplant rejection. Available in 0.5 mg, 1 mg, 3 mg, 4 mg, and 5 mg strengths in both immediate-release and extended-release forms across the U.S. and EU, they support personalized post-transplant care. Ideal for B2B pharma supply.
Tacrolimus Capsules are essential immunosuppressants widely used in organ transplant patients to prevent rejection. Available in both immediate-release (Prograf) and extended-release forms (Astagraf XL, Envarsus), these capsules are offered in strengths of 0.5 mg, 1 mg, 3 mg, 4 mg, and 5 mg across the U.S. and EU markets. Tacrolimus effectively inhibits T-lymphocyte activation, making it a vital part of post-transplant care. With multiple dosing options, it supports individualized therapy. Suitable for B2B pharmaceutical distribution, Tacrolimus capsules are available in branded and generic forms, ensuring broad accessibility and cost-effective solutions for hospitals, clinics, and healthcare providers in Europe and the U.S.